The sheet summarizes the result of a retrospective clinical trial concerning calcaneal fractures, published in 2017 in The Journal of Foot & Ankle Surgery, concerning patients who were treated either with chips or blocks derived from cancellous tissue (Osteoplant, Bioteck) or with a homologous graft. Retrospective analysis showed that the distribution and presence of complications, expected in this type of surgery, did not vary significantly between the two groups. At the last follow-up, the patients had overlapping functional scores. The authors conclude that the equine bone substitute appears to be a valid alternative to the use of homologous bone tissue.
Vicenza
Headquarter
via E. Fermi, 49
36057 Arcugnano, Vicenza (VI) - Italy
Tel. +39 0444 289366
Fax: +39 0444 285272
Torino
Multi-function production center
Via G. Agnelli, 3
10020 Riva presso Chieri, Torino (TO) - Italy
Copyright © 2024 Bioteck S.p.A. - Privacy Policy - Cookie Policy